Tapewire

NYSE · USD

JNJ

JOHNSON & JOHNSON

Export transactions ↓
Tapewire entity
2722
SEC CIK
0000200406
Parsed reports
1,771

Last 12 months

Inside the activity.

1 purchase rows · 28 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202510
Dec 202500
Jan 202602
Feb 2026015
Mar 202600
Apr 202600
May 202600
Jun 202601
Jul 202601
Aug 202607
Sep 202602
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
April 25, 2024 Filed Apr 29, 2024 21:06 UTC
West NadjaDirector
GrantDeferred Share Units · Derivative 1,385.697 $0.00 $0.00
Disclosure

SEC source: 0001225208-24-005334 · doc4.xml · derivative · entry 1

West Nadja · CIK 0001787802 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,093.682

Underlying: Common Stock · 1,385.697 shares

Expires not disclosed

F1 · derivative.exercise_price: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.exercise_date: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.expiration_date: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).

F2 · balance_after: Includes dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the Reporting Person on DSUs held by the Reporting Person.

Read SEC document
April 25, 2024 Filed Apr 29, 2024 21:06 UTC GrantDeferred Share Units · Derivative 1,385.697 $0.00 $0.00
Disclosure

SEC source: 0001225208-24-005335 · doc4.xml · derivative · entry 1

Woods Eugene A. · CIK 0001762647 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,139.143

Underlying: Common Stock · 1,385.697 shares

Expires not disclosed

F1 · derivative.exercise_price: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.exercise_date: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.expiration_date: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).

F2 · balance_after: Includes dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the Reporting Person on DSUs held by the Reporting Person.

Read SEC document
April 25, 2024 Filed Apr 29, 2024 21:06 UTC GrantDeferred Share Units · Derivative 1,385.697 $0.00 $0.00
Disclosure

SEC source: 0001225208-24-005336 · doc4.xml · derivative · entry 1

Adamczyk Darius · CIK 0001605056 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,712.704

Underlying: Common Stock · 1,385.697 shares

Expires not disclosed

F1 · derivative.exercise_price: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.exercise_date: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.expiration_date: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).

F2 · balance_after: Includes dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the Reporting Person on DSUs held by the Reporting Person.

Read SEC document
April 25, 2024 Filed Apr 29, 2024 21:06 UTC GrantDeferred Share Units · Derivative 1,385.697 $0.00 $0.00
Disclosure

SEC source: 0001225208-24-005337 · doc4.xml · derivative · entry 1

HEWSON MARILLYN A · CIK 0001217496 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,173.4414

Underlying: Common Stock · 1,385.697 shares

Expires not disclosed

F1 · derivative.exercise_price: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.exercise_date: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.expiration_date: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).

F2 · derivative.underlying_shares: Includes dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the Reporting Person on DSUs held by the Reporting Person.

Read SEC document
April 25, 2024 Filed Apr 29, 2024 21:06 UTC GrantDeferred Share Units · Derivative 1,385.697 $0.00 $0.00
Disclosure

SEC source: 0001225208-24-005338 · doc4.xml · derivative · entry 1

Beckerle Mary C · CIK 0001520181 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,643.012

Underlying: Common Stock · 1,385.697 shares

Expires not disclosed

F1 · derivative.exercise_price: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.exercise_date: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.expiration_date: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).

F2 · balance_after: Includes dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the Reporting Person on DSUs held by the Reporting Person.

Read SEC document
April 25, 2024 Filed Oct 15, 2024 20:39 UTC GrantDeferred Share Units · Derivative 1,385.697 $0.00 $0.00
Disclosure

SEC source: 0001225208-24-009300 · doc4.xml · derivative · entry 1

DAVIS D SCOTT · CIK 0001227733 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,603.677

Underlying: Common Stock · 1,385.697 shares

Expires not disclosed

F1 · derivative.exercise_price: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.exercise_date: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.expiration_date: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).

F2 · balance_after: Includes dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the Reporting Person on DSUs held by the Reporting Person.

Read SEC document
March 13, 2024 Filed Mar 13, 2024 20:36 UTC
Broadhurst VanessaEVP, Global Corp Affairs
SaleCommon Stock 8,891 $162.16 $1,441,764.56
Disclosure

SEC source: 0001225208-24-004185 · doc4.xml · nonDerivative · entry 1

Broadhurst Vanessa · CIK 0001904787 · EVP, Global Corp Affairs

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,043

F1 · price: This transaction was executed in multiple trades at prices ranging from 161.95 to 162.33 . The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
March 05, 2024 Filed Mar 7, 2024 21:58 UTC GrantDeferred Share Units · Derivative 234.6683 $159.80 $37,499.99
Disclosure

SEC source: 0001225208-24-003852 · doc4.xml · derivative · entry 1

HEWSON MARILLYN A · CIK 0001217496 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,787.7444

Underlying: Common Stock · 234.6683 shares

Expires not disclosed

F1 · derivative.exercise_price: Acquisition of Deferred Share Units (DSU) for deferral of cash retainer under the Issuer's Amended and Restated Deferred Fee Plan for Directors. DSUs are to be settled in cash upon termination of the Reporting Person's directorship. Each DSU represents the fair market value of one share of Common Stock on the business day prior to settlement date.

F1 · derivative.exercise_date: Acquisition of Deferred Share Units (DSU) for deferral of cash retainer under the Issuer's Amended and Restated Deferred Fee Plan for Directors. DSUs are to be settled in cash upon termination of the Reporting Person's directorship. Each DSU represents the fair market value of one share of Common Stock on the business day prior to settlement date.

F1 · derivative.expiration_date: Acquisition of Deferred Share Units (DSU) for deferral of cash retainer under the Issuer's Amended and Restated Deferred Fee Plan for Directors. DSUs are to be settled in cash upon termination of the Reporting Person's directorship. Each DSU represents the fair market value of one share of Common Stock on the business day prior to settlement date.

F2 · balance_after: Includes dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the Reporting Person on DSUs held by the Reporting Person.

Read SEC document
March 05, 2024 Filed Mar 7, 2024 21:58 UTC GrantDeferred Share Units · Derivative 261.993 $159.80 $41,866.48
Disclosure

SEC source: 0001225208-24-003853 · doc4.xml · derivative · entry 2

Woods Eugene A. · CIK 0001762647 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 753.446

Underlying: Common Stock · 261.993 shares

Expires not disclosed

F1 · derivative.exercise_price: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).

F2 · derivative.exercise_date: Acquisition of Deferred Share Units (DSU) for deferral of cash retainer under the Issuer's Amended and Restated Deferred Fee Plan for Directors. DSUs are to be settled in cash upon termination of the Reporting Person's directorship. Each DSU represents the fair market value of one share of Common Stock on the business day prior to settlement date.

F2 · derivative.expiration_date: Acquisition of Deferred Share Units (DSU) for deferral of cash retainer under the Issuer's Amended and Restated Deferred Fee Plan for Directors. DSUs are to be settled in cash upon termination of the Reporting Person's directorship. Each DSU represents the fair market value of one share of Common Stock on the business day prior to settlement date.

Read SEC document
March 05, 2024 Filed Mar 7, 2024 21:58 UTC GrantDeferred Share Units · Derivative 491.453 $159.80 $78,534.19
Disclosure

SEC source: 0001225208-24-003853 · doc4.xml · derivative · entry 1

Woods Eugene A. · CIK 0001762647 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 491.453

Underlying: Common Stock · 491.453 shares

Expires not disclosed

F1 · derivative.exercise_price: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.exercise_date: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.expiration_date: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).

Read SEC document
February 15, 2024 Filed Feb 20, 2024 22:54 UTC
Decker Robert JVP Corporate Controller
GrantRestricted Share Units · Derivative 1,016 $0.00 $0.00
Disclosure

SEC source: 0001225208-24-002527 · doc4.xml · derivative · entry 2

Decker Robert J · CIK 0001798703 · VP Corporate Controller

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,016

Underlying: Common Stock · 1,016 shares

Expires 2034-02-15

F2 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to acquire one share of Common Stock.

F3 · derivative.exercise_date: The Restricted Share Units vest in three equal annual installments beginning on the first anniversary of the grant date.

F3 · derivative.expiration_date: The Restricted Share Units vest in three equal annual installments beginning on the first anniversary of the grant date.

Read SEC document
February 15, 2024 Filed Feb 20, 2024 22:54 UTC
Decker Robert JVP Corporate Controller
GrantEmployee Stock Options (Right to Buy) · Derivative 8,175 $0.00 Strike: $157.92 $0.00
Disclosure

SEC source: 0001225208-24-002527 · doc4.xml · derivative · entry 1

Decker Robert J · CIK 0001798703 · VP Corporate Controller

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,175

Underlying: Common Stock · 8,175 shares

Expires 2034-02-15

F1 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests in three equal annual installments beginning on the first anniversary of the grant date.

Read SEC document
February 15, 2024 Filed Feb 20, 2024 22:54 UTC
Fasolo PeterExec VP, Chief HR Officer
GrantRestricted Share Units · Derivative 2,519 $0.00 $0.00
Disclosure

SEC source: 0001225208-24-002528 · doc4.xml · derivative · entry 2

Fasolo Peter · CIK 0001509999 · Exec VP, Chief HR Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,519

Underlying: Common Stock · 2,519 shares

Expires 2034-02-15

F2 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to acquire one share of Common Stock.

F3 · derivative.exercise_date: The Restricted Share Units vest in three equal annual installments beginning on the first anniversary of the grant date.

F3 · derivative.expiration_date: The Restricted Share Units vest in three equal annual installments beginning on the first anniversary of the grant date.

Read SEC document
February 15, 2024 Filed Feb 20, 2024 22:54 UTC
Fasolo PeterExec VP, Chief HR Officer
GrantEmployee Stock Options (Right to Buy) · Derivative 40,551 $0.00 Strike: $157.92 $0.00
Disclosure

SEC source: 0001225208-24-002528 · doc4.xml · derivative · entry 1

Fasolo Peter · CIK 0001509999 · Exec VP, Chief HR Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,551

Underlying: Common Stock · 40,551 shares

Expires 2034-02-15

F1 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests in three equal annual installments beginning on the first anniversary of the grant date.

Read SEC document
February 15, 2024 Filed Feb 20, 2024 22:54 UTC
Duato JoaquinDirector · CEO and Chairman of the Board
GrantRestricted Share Units · Derivative 11,046 $0.00 $0.00
Disclosure

SEC source: 0001225208-24-002529 · doc4.xml · derivative · entry 2

Duato Joaquin · CIK 0001673401 · Director · CEO and Chairman of the Board

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,046

Underlying: Common Stock · 11,046 shares

Expires 2034-02-15

F2 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to acquire one share of Common Stock.

F3 · derivative.exercise_date: The Restricted Share Units vest in three equal annual installments beginning on the first anniversary of the grant date.

F3 · derivative.expiration_date: The Restricted Share Units vest in three equal annual installments beginning on the first anniversary of the grant date.

Read SEC document
February 15, 2024 Filed Feb 20, 2024 22:54 UTC
Duato JoaquinDirector · CEO and Chairman of the Board
GrantEmployee Stock Options (Right to Buy) · Derivative 177,816 $0.00 Strike: $157.92 $0.00
Disclosure

SEC source: 0001225208-24-002529 · doc4.xml · derivative · entry 1

Duato Joaquin · CIK 0001673401 · Director · CEO and Chairman of the Board

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 177,816

Underlying: Common Stock · 177,816 shares

Expires 2034-02-15

F1 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests in three equal annual installments beginning on the first anniversary of the grant date.

Read SEC document
February 15, 2024 Filed Feb 20, 2024 22:54 UTC
Broadhurst VanessaEVP, Global Corp Affairs
GrantRestricted Share Units · Derivative 1,475 $0.00 $0.00
Disclosure

SEC source: 0001225208-24-002530 · doc4.xml · derivative · entry 2

Broadhurst Vanessa · CIK 0001904787 · EVP, Global Corp Affairs

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,475

Underlying: Common Stock · 1,475 shares

Expires 2034-02-15

F2 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to acquire one share of Common Stock.

F3 · derivative.exercise_date: The Restricted Share Units vest in three equal annual installments beginning on the first anniversary of the grant date.

F3 · derivative.expiration_date: The Restricted Share Units vest in three equal annual installments beginning on the first anniversary of the grant date.

Read SEC document
February 15, 2024 Filed Feb 20, 2024 22:54 UTC
Broadhurst VanessaEVP, Global Corp Affairs
GrantEmployee Stock Options (Right to Buy) · Derivative 23,745 $0.00 Strike: $157.92 $0.00
Disclosure

SEC source: 0001225208-24-002530 · doc4.xml · derivative · entry 1

Broadhurst Vanessa · CIK 0001904787 · EVP, Global Corp Affairs

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,745

Underlying: Common Stock · 23,745 shares

Expires 2034-02-15

F1 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests in three equal annual installments beginning on the first anniversary of the grant date.

Read SEC document
February 15, 2024 Filed Feb 20, 2024 22:55 UTC
Forminard ElizabethExecutive VP, General Counsel
GrantRestricted Share Units · Derivative 2,883 $0.00 $0.00
Disclosure

SEC source: 0001225208-24-002531 · doc4.xml · derivative · entry 2

Forminard Elizabeth · CIK 0001950802 · Executive VP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,883

Underlying: Common Stock · 2,883 shares

Expires 2034-02-15

F2 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to acquire one share of Common Stock.

F3 · derivative.exercise_date: The Restricted Share Units vest in three equal annual installments beginning on the first anniversary of the grant date.

F3 · derivative.expiration_date: The Restricted Share Units vest in three equal annual installments beginning on the first anniversary of the grant date.

Read SEC document
February 15, 2024 Filed Feb 20, 2024 22:55 UTC
Forminard ElizabethExecutive VP, General Counsel
GrantEmployee Stock Options (Right to Buy) · Derivative 46,406 $0.00 Strike: $157.92 $0.00
Disclosure

SEC source: 0001225208-24-002531 · doc4.xml · derivative · entry 1

Forminard Elizabeth · CIK 0001950802 · Executive VP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 46,406

Underlying: Common Stock · 46,406 shares

Expires 2034-02-15

F1 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests in three equal annual installments beginning on the first anniversary of the grant date.

Read SEC document
February 15, 2024 Filed Feb 20, 2024 22:55 UTC
Hait WilliamEVP, Chief EI and Med Officer
GrantRestricted Share Units · Derivative 2,155 $0.00 $0.00
Disclosure

SEC source: 0001225208-24-002532 · doc4.xml · derivative · entry 2

Hait William · CIK 0001904791 · EVP, Chief EI and Med Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,155

Underlying: Common Stock · 2,155 shares

Expires 2034-02-15

F2 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to acquire one share of Common Stock.

F3 · derivative.exercise_date: The Restricted Share Units vest in three equal annual installments beginning on the first anniversary of the grant date.

F3 · derivative.expiration_date: The Restricted Share Units vest in three equal annual installments beginning on the first anniversary of the grant date.

Read SEC document
February 15, 2024 Filed Feb 20, 2024 22:55 UTC
Hait WilliamEVP, Chief EI and Med Officer
GrantEmployee Stock Options (Right to Buy) · Derivative 34,696 $0.00 Strike: $157.92 $0.00
Disclosure

SEC source: 0001225208-24-002532 · doc4.xml · derivative · entry 1

Hait William · CIK 0001904791 · EVP, Chief EI and Med Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,696

Underlying: Common Stock · 34,696 shares

Expires 2034-02-15

F1 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests in three equal annual installments beginning on the first anniversary of the grant date.

Read SEC document
February 15, 2024 Filed Feb 20, 2024 22:55 UTC GrantRestricted Share Units · Derivative 1,475 $0.00 $0.00
Disclosure

SEC source: 0001225208-24-002533 · doc4.xml · derivative · entry 2

Swanson James D. · CIK 0001904785 · EVP, CIO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,475

Underlying: Common Stock · 1,475 shares

Expires 2034-02-15

F2 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to acquire one share of Common Stock.

F3 · derivative.exercise_date: The Restricted Share Units vest in three equal annual installments beginning on the first anniversary of the grant date.

F3 · derivative.expiration_date: The Restricted Share Units vest in three equal annual installments beginning on the first anniversary of the grant date.

Read SEC document
February 15, 2024 Filed Feb 20, 2024 22:55 UTC GrantEmployee Stock Options (Right to Buy) · Derivative 23,745 $0.00 Strike: $157.92 $0.00
Disclosure

SEC source: 0001225208-24-002533 · doc4.xml · derivative · entry 1

Swanson James D. · CIK 0001904785 · EVP, CIO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,745

Underlying: Common Stock · 23,745 shares

Expires 2034-02-15

F1 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests in three equal annual installments beginning on the first anniversary of the grant date.

Read SEC document
February 15, 2024 Filed Feb 20, 2024 22:55 UTC
REED JOHN CEVP, Innovative Medicine, R&D
GrantRestricted Share Units · Derivative 4,048 $0.00 $0.00
Disclosure

SEC source: 0001225208-24-002534 · doc4.xml · derivative · entry 2

REED JOHN C · CIK 0001181561 · EVP, Innovative Medicine, R&D

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,048

Underlying: Common Stock · 4,048 shares

Expires 2034-02-15

F2 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to acquire one share of Common Stock.

F3 · derivative.exercise_date: The Restricted Share Units vest in three equal annual installments beginning on the first anniversary of the grant date.

F3 · derivative.expiration_date: The Restricted Share Units vest in three equal annual installments beginning on the first anniversary of the grant date.

Read SEC document
February 15, 2024 Filed Feb 20, 2024 22:55 UTC
REED JOHN CEVP, Innovative Medicine, R&D
GrantEmployee Stock Options (Right to Buy) · Derivative 65,163 $0.00 Strike: $157.92 $0.00
Disclosure

SEC source: 0001225208-24-002534 · doc4.xml · derivative · entry 1

REED JOHN C · CIK 0001181561 · EVP, Innovative Medicine, R&D

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 65,163

Underlying: Common Stock · 65,163 shares

Expires 2034-02-15

F1 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests in three equal annual installments beginning on the first anniversary of the grant date.

Read SEC document
February 15, 2024 Filed Feb 20, 2024 22:56 UTC
Schmid TimothyEVP, WW Chair, MedTech
GrantRestricted Share Units · Derivative 3,085 $0.00 $0.00
Disclosure

SEC source: 0001225208-24-002535 · doc4.xml · derivative · entry 2

Schmid Timothy · CIK 0001998491 · EVP, WW Chair, MedTech

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,085

Underlying: Common Stock · 3,085 shares

Expires 2034-02-15

F2 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to acquire one share of Common Stock.

F3 · derivative.exercise_date: The Restricted Share Units vest in three equal annual installments beginning on the first anniversary of the grant date.

F3 · derivative.expiration_date: The Restricted Share Units vest in three equal annual installments beginning on the first anniversary of the grant date.

Read SEC document
February 15, 2024 Filed Feb 20, 2024 22:56 UTC
Schmid TimothyEVP, WW Chair, MedTech
GrantEmployee Stock Options (Right to Buy) · Derivative 49,658 $0.00 Strike: $157.92 $0.00
Disclosure

SEC source: 0001225208-24-002535 · doc4.xml · derivative · entry 1

Schmid Timothy · CIK 0001998491 · EVP, WW Chair, MedTech

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 49,658

Underlying: Common Stock · 49,658 shares

Expires 2034-02-15

F1 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests in three equal annual installments beginning on the first anniversary of the grant date.

Read SEC document
February 15, 2024 Filed Feb 20, 2024 22:58 UTC
Taubert Jennifer LEVP, WWC. Innovative Medicine
GrantRestricted Share Units · Derivative 4,782 $0.00 $0.00
Disclosure

SEC source: 0001225208-24-002536 · doc4.xml · derivative · entry 2

Taubert Jennifer L · CIK 0001745938 · EVP, WWC. Innovative Medicine

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,782

Underlying: Common Stock · 4,782 shares

Expires 2034-02-15

F2 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to acquire one share of Common Stock.

F3 · derivative.exercise_date: The Restricted Share Units vest in three equal annual installments beginning on the first anniversary of the grant date.

F3 · derivative.expiration_date: The Restricted Share Units vest in three equal annual installments beginning on the first anniversary of the grant date.

Read SEC document
February 15, 2024 Filed Feb 20, 2024 22:58 UTC
Taubert Jennifer LEVP, WWC. Innovative Medicine
GrantEmployee Stock Options (Right to Buy) · Derivative 76,981 $0.00 Strike: $157.92 $0.00
Disclosure

SEC source: 0001225208-24-002536 · doc4.xml · derivative · entry 1

Taubert Jennifer L · CIK 0001745938 · EVP, WWC. Innovative Medicine

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 76,981

Underlying: Common Stock · 76,981 shares

Expires 2034-02-15

F1 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests in three equal annual installments beginning on the first anniversary of the grant date.

Read SEC document
February 15, 2024 Filed Feb 20, 2024 22:56 UTC
Wengel Kathryn EEVP, Chief TO and Risk Officer
GrantRestricted Share Units · Derivative 1,819 $0.00 $0.00
Disclosure

SEC source: 0001225208-24-002537 · doc4.xml · derivative · entry 2

Wengel Kathryn E · CIK 0001745955 · EVP, Chief TO and Risk Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,819

Underlying: Common Stock · 1,819 shares

Expires 2034-02-15

F2 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to acquire one share of Common Stock.

F3 · derivative.exercise_date: The Restricted Share Units vest in three equal annual installments beginning on the first anniversary of the grant date.

F3 · derivative.expiration_date: The Restricted Share Units vest in three equal annual installments beginning on the first anniversary of the grant date.

Read SEC document
February 15, 2024 Filed Feb 20, 2024 22:56 UTC
Wengel Kathryn EEVP, Chief TO and Risk Officer
GrantEmployee Stock Options (Right to Buy) · Derivative 29,275 $0.00 Strike: $157.92 $0.00
Disclosure

SEC source: 0001225208-24-002537 · doc4.xml · derivative · entry 1

Wengel Kathryn E · CIK 0001745955 · EVP, Chief TO and Risk Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,275

Underlying: Common Stock · 29,275 shares

Expires 2034-02-15

F1 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests in three equal annual installments beginning on the first anniversary of the grant date.

Read SEC document
February 15, 2024 Filed Feb 20, 2024 22:55 UTC
Wolk Joseph JExec VP, CFO
GrantRestricted Share Units · Derivative 5,913 $0.00 $0.00
Disclosure

SEC source: 0001225208-24-002538 · doc4.xml · derivative · entry 2

Wolk Joseph J · CIK 0001744564 · Exec VP, CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,913

Underlying: Common Stock · 5,913 shares

Expires 2034-02-15

F2 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to acquire one share of Common Stock.

F3 · derivative.exercise_date: The Restricted Share Units vest in three equal annual installments beginning on the first anniversary of the grant date.

F3 · derivative.expiration_date: The Restricted Share Units vest in three equal annual installments beginning on the first anniversary of the grant date.

Read SEC document
February 15, 2024 Filed Feb 20, 2024 22:55 UTC
Wolk Joseph JExec VP, CFO
GrantEmployee Stock Options (Right to Buy) · Derivative 95,197 $0.00 Strike: $157.92 $0.00
Disclosure

SEC source: 0001225208-24-002538 · doc4.xml · derivative · entry 1

Wolk Joseph J · CIK 0001744564 · Exec VP, CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 95,197

Underlying: Common Stock · 95,197 shares

Expires 2034-02-15

F1 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests in three equal annual installments beginning on the first anniversary of the grant date.

Read SEC document
February 13, 2024 Filed Feb 15, 2024 21:53 UTC
Decker Robert JVP Corporate Controller
Exercise / conversionRestricted Share Units · Derivative 313 $0.00 $0.00
Disclosure

SEC source: 0001225208-24-002173 · doc4.xml · derivative · entry 5

Decker Robert J · CIK 0001798703 · VP Corporate Controller

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 624

Underlying: Common Stock · 313 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The Restricted Share Units awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The Restricted Share Units converted into shares of Common Stock upon vesting.

F1 · derivative.exercise_date: The Restricted Share Units awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The Restricted Share Units converted into shares of Common Stock upon vesting.

F1 · derivative.expiration_date: The Restricted Share Units awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The Restricted Share Units converted into shares of Common Stock upon vesting.

Read SEC document
February 13, 2024 Filed Feb 15, 2024 21:53 UTC
Decker Robert JVP Corporate Controller
Tax withholdingCommon Stock 86 $157.85 $13,575.10
Disclosure

SEC source: 0001225208-24-002173 · doc4.xml · nonDerivative · entry 2

Decker Robert J · CIK 0001798703 · VP Corporate Controller

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,973

F2 · shares: Shares withheld for payment of taxes upon vesting of Restricted Share Units.

Read SEC document
February 13, 2024 Filed Feb 15, 2024 21:53 UTC
Decker Robert JVP Corporate Controller
Exercise / conversionCommon Stock 313 $0.00 $0.00
Disclosure

SEC source: 0001225208-24-002173 · doc4.xml · nonDerivative · entry 1

Decker Robert J · CIK 0001798703 · VP Corporate Controller

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,059

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: The Restricted Share Units awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The Restricted Share Units converted into shares of Common Stock upon vesting.

Read SEC document
February 13, 2024 Filed Feb 15, 2024 21:53 UTC
Broadhurst VanessaEVP, Global Corp Affairs
Exercise / conversionRestricted Share Units · Derivative 408 $0.00 $0.00
Disclosure

SEC source: 0001225208-24-002174 · doc4.xml · derivative · entry 3

Broadhurst Vanessa · CIK 0001904787 · EVP, Global Corp Affairs

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 816

Underlying: Common Stock · 408 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The Restricted Share Units awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The Restricted Share Units converted into shares of Common Stock upon vesting.

F1 · derivative.exercise_date: The Restricted Share Units awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The Restricted Share Units converted into shares of Common Stock upon vesting.

F1 · derivative.expiration_date: The Restricted Share Units awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The Restricted Share Units converted into shares of Common Stock upon vesting.

Read SEC document
February 13, 2024 Filed Feb 15, 2024 21:53 UTC
Broadhurst VanessaEVP, Global Corp Affairs
Tax withholdingCommon Stock 209 $157.85 $32,990.65
Disclosure

SEC source: 0001225208-24-002174 · doc4.xml · nonDerivative · entry 2

Broadhurst Vanessa · CIK 0001904787 · EVP, Global Corp Affairs

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,934

F2 · shares: Shares withheld for payment of taxes upon vesting of Restricted Share Units.

Read SEC document
February 13, 2024 Filed Feb 15, 2024 21:53 UTC
Broadhurst VanessaEVP, Global Corp Affairs
Exercise / conversionCommon Stock 408 $0.00 $0.00
Disclosure

SEC source: 0001225208-24-002174 · doc4.xml · nonDerivative · entry 1

Broadhurst Vanessa · CIK 0001904787 · EVP, Global Corp Affairs

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,143

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: The Restricted Share Units awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The Restricted Share Units converted into shares of Common Stock upon vesting.

Read SEC document
February 13, 2024 Filed Feb 15, 2024 21:53 UTC
Duato JoaquinDirector · CEO and Chairman of the Board
Exercise / conversionRestricted Share Units · Derivative 3,470 $0.00 $0.00
Disclosure

SEC source: 0001225208-24-002175 · doc4.xml · derivative · entry 4

Duato Joaquin · CIK 0001673401 · Director · CEO and Chairman of the Board

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,939

Underlying: Common Stock · 3,470 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The Restricted Share Units awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The Restricted Share Units converted into shares of Common Stock upon vesting.

F1 · derivative.exercise_date: The Restricted Share Units awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The Restricted Share Units converted into shares of Common Stock upon vesting.

F1 · derivative.expiration_date: The Restricted Share Units awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The Restricted Share Units converted into shares of Common Stock upon vesting.

Read SEC document
February 13, 2024 Filed Feb 15, 2024 21:53 UTC
Duato JoaquinDirector · CEO and Chairman of the Board
Tax withholdingCommon Stock 1,507 $157.85 $237,879.95
Disclosure

SEC source: 0001225208-24-002175 · doc4.xml · nonDerivative · entry 2

Duato Joaquin · CIK 0001673401 · Director · CEO and Chairman of the Board

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 363,302

F2 · shares: Shares withheld for payment of taxes upon vesting of Restricted Share Units.

Read SEC document
February 13, 2024 Filed Feb 15, 2024 21:53 UTC
Duato JoaquinDirector · CEO and Chairman of the Board
Exercise / conversionCommon Stock 3,470 $0.00 $0.00
Disclosure

SEC source: 0001225208-24-002175 · doc4.xml · nonDerivative · entry 1

Duato Joaquin · CIK 0001673401 · Director · CEO and Chairman of the Board

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 364,809

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: The Restricted Share Units awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The Restricted Share Units converted into shares of Common Stock upon vesting.

Read SEC document
February 13, 2024 Filed Feb 15, 2024 21:53 UTC
Fasolo PeterExec VP, Chief HR Officer
Exercise / conversionRestricted Share Units · Derivative 925 $0.00 $0.00
Disclosure

SEC source: 0001225208-24-002176 · doc4.xml · derivative · entry 3

Fasolo Peter · CIK 0001509999 · Exec VP, Chief HR Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,848

Underlying: Common Stock · 925 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The Restricted Share Units awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The Restricted Share Units converted into shares of Common Stock upon vesting.

F1 · derivative.exercise_date: The Restricted Share Units awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The Restricted Share Units converted into shares of Common Stock upon vesting.

F1 · derivative.expiration_date: The Restricted Share Units awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The Restricted Share Units converted into shares of Common Stock upon vesting.

Read SEC document
February 13, 2024 Filed Feb 15, 2024 21:53 UTC
Fasolo PeterExec VP, Chief HR Officer
Tax withholdingCommon Stock 474 $157.85 $74,820.90
Disclosure

SEC source: 0001225208-24-002176 · doc4.xml · nonDerivative · entry 2

Fasolo Peter · CIK 0001509999 · Exec VP, Chief HR Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 112,076

F2 · shares: Shares withheld for payment of taxes upon vesting of Restricted Share Units.

Read SEC document
February 13, 2024 Filed Feb 15, 2024 21:53 UTC
Fasolo PeterExec VP, Chief HR Officer
Exercise / conversionCommon Stock 925 $0.00 $0.00
Disclosure

SEC source: 0001225208-24-002176 · doc4.xml · nonDerivative · entry 1

Fasolo Peter · CIK 0001509999 · Exec VP, Chief HR Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 112,550

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: The Restricted Share Units awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The Restricted Share Units converted into shares of Common Stock upon vesting.

Read SEC document
February 13, 2024 Filed Feb 15, 2024 21:53 UTC
Forminard ElizabethExecutive VP, General Counsel
Exercise / conversionRestricted Share Units · Derivative 651 $0.00 $0.00
Disclosure

SEC source: 0001225208-24-002177 · doc4.xml · derivative · entry 3

Forminard Elizabeth · CIK 0001950802 · Executive VP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,302

Underlying: Common Stock · 651 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The Restricted Share Units awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The Restricted Share Units converted into shares of Common Stock upon vesting.

F1 · derivative.exercise_date: The Restricted Share Units awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The Restricted Share Units converted into shares of Common Stock upon vesting.

F1 · derivative.expiration_date: The Restricted Share Units awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The Restricted Share Units converted into shares of Common Stock upon vesting.

Read SEC document
February 13, 2024 Filed Feb 15, 2024 21:53 UTC
Forminard ElizabethExecutive VP, General Counsel
Tax withholdingCommon Stock 236 $157.85 $37,252.60
Disclosure

SEC source: 0001225208-24-002177 · doc4.xml · nonDerivative · entry 2

Forminard Elizabeth · CIK 0001950802 · Executive VP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,340

F2 · shares: Shares withheld for payment of taxes upon vesting of Restricted Share Units.

Read SEC document
February 13, 2024 Filed Feb 15, 2024 21:53 UTC
Forminard ElizabethExecutive VP, General Counsel
Exercise / conversionCommon Stock 651 $0.00 $0.00
Disclosure

SEC source: 0001225208-24-002177 · doc4.xml · nonDerivative · entry 1

Forminard Elizabeth · CIK 0001950802 · Executive VP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,576

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: The Restricted Share Units awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The Restricted Share Units converted into shares of Common Stock upon vesting.

Read SEC document
February 13, 2024 Filed Feb 15, 2024 21:53 UTC
Hait WilliamSee Remarks
Exercise / conversionRestricted Share Units · Derivative 834 $0.00 $0.00
Disclosure

SEC source: 0001225208-24-002178 · doc4.xml · derivative · entry 3

Hait William · CIK 0001904791 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,666

Underlying: Common Stock · 834 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The Restricted Share Units awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The Restricted Share Units converted into shares of Common Stock upon vesting.

F1 · derivative.exercise_date: The Restricted Share Units awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The Restricted Share Units converted into shares of Common Stock upon vesting.

F1 · derivative.expiration_date: The Restricted Share Units awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The Restricted Share Units converted into shares of Common Stock upon vesting.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.